rs2271101

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000027.4(AGA):​c.507+180T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.448 in 151,966 control chromosomes in the GnomAD database, including 15,461 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 15461 hom., cov: 32)

Consequence

AGA
NM_000027.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.891

Publications

18 publications found
Variant links:
Genes affected
AGA (HGNC:318): (aspartylglucosaminidase) This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015]
AGA Gene-Disease associations (from GenCC):
  • aspartylglucosaminuria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-177438565-A-G is Benign according to our data. Variant chr4-177438565-A-G is described in ClinVar as Benign. ClinVar VariationId is 1254787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGANM_000027.4 linkc.507+180T>C intron_variant Intron 4 of 8 ENST00000264595.7 NP_000018.2 P20933
AGANM_001171988.2 linkc.507+180T>C intron_variant Intron 4 of 8 NP_001165459.1 P20933
AGANR_033655.2 linkn.569+180T>C intron_variant Intron 4 of 7
AGAXM_047449722.1 linkc.507+180T>C intron_variant Intron 4 of 6 XP_047305678.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGAENST00000264595.7 linkc.507+180T>C intron_variant Intron 4 of 8 1 NM_000027.4 ENSP00000264595.2 P20933

Frequencies

GnomAD3 genomes
AF:
0.448
AC:
68058
AN:
151848
Hom.:
15429
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.445
Gnomad AMI
AF:
0.383
Gnomad AMR
AF:
0.447
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.297
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.486
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.470
Gnomad OTH
AF:
0.422
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.448
AC:
68136
AN:
151966
Hom.:
15461
Cov.:
32
AF XY:
0.444
AC XY:
32958
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.445
AC:
18453
AN:
41424
American (AMR)
AF:
0.447
AC:
6825
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1392
AN:
3472
East Asian (EAS)
AF:
0.298
AC:
1536
AN:
5162
South Asian (SAS)
AF:
0.317
AC:
1523
AN:
4812
European-Finnish (FIN)
AF:
0.486
AC:
5126
AN:
10542
Middle Eastern (MID)
AF:
0.405
AC:
119
AN:
294
European-Non Finnish (NFE)
AF:
0.470
AC:
31929
AN:
67972
Other (OTH)
AF:
0.419
AC:
885
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1941
3882
5822
7763
9704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.459
Hom.:
8498
Bravo
AF:
0.450
Asia WGS
AF:
0.332
AC:
1157
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.2
DANN
Benign
0.54
PhyloP100
-0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2271101; hg19: chr4-178359719; COSMIC: COSV107277890; COSMIC: COSV107277890; API